Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas
| author |
|
| created | [InstanceEdit:9710764] Rothfels, Karen, 2021-01-05 |
| dbId | 9710767 |
| displayName | Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas |
| journal | PLoS One |
| pages | e18436 |
| pubMedIdentifier | 21494621 |
| schemaClass | LiteratureReference |
| title | Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas |
| url | http://www.ncbi.nlm.nih.gov/pubmed/21494621 |
| volume | 6 |
| year | 2011 |
Referrals
© 2026 Reactome
